1.Respiratory Viral Infections after Hematopoietic Stem Cell Transplantation in Children.
Jae Hong CHOI ; Eun Hwa CHOI ; Hyoung Jin KANG ; Kyung Duk PARK ; Sung Sup PARK ; Hee Young SHIN ; Hoan Jong LEE ; Hyo Seop AHN
Journal of Korean Medical Science 2013;28(1):36-41
This study was performed to characterize respiratory viral infections in pediatric patients undergoing hematopoietic stem cell transplantation (HSCT). Study samples included 402 respiratory specimens obtained from 358 clinical episodes that occurred in the 116 children of the 175 consecutive HSCT cohort at Seoul National University Children's Hospital, Korea from 2007 to 2010. Multiplex reverse-transcription polymerase chain reactions were performed for rhinovirus, respiratory syncytial virus (RSV), parainfluenza viruses (PIVs), adenovirus, human coronavirus (hCoV), influenza viruses and human metapneumovirus. Viruses were identified in 89 clinical episodes that occurred in 58 patients. Among the 89 clinical episodes, frequently detected viruses were rhinovirus in 25 (28.1%), RSV in 23 (25.8%), PIV-3 in 16 (18.0%), adenovirus in 12 (13.5%), and hCoV in 10 (11.2%). Lower respiratory tract infections were diagnosed in 34 (38.2%). Neutropenia was present in 24 (27.0%) episodes and lymphopenia was in 31 (34.8%) episodes. Sixty-three percent of the clinical episodes were hospital-acquired. Three patients died of respiratory failure caused by respiratory viral infections. Respiratory viral infections in pediatric patients who have undergone HSCT are common and are frequently acquired during hospitalization. Continuous monitoring is required to determine the role of respiratory viruses in immunocompromised children and the importance of preventive strategies.
Adenoviridae/genetics/isolation & purification
;
Adolescent
;
Adult
;
Child
;
Child, Preschool
;
Cohort Studies
;
Coronavirus/genetics/isolation & purification
;
Female
;
*Hematopoietic Stem Cell Transplantation
;
Hematopoietic Stem Cells/cytology
;
Hospitalization
;
Humans
;
Infant
;
Lymphopenia/epidemiology
;
Male
;
Neutropenia/epidemiology
;
Parainfluenza Virus 3, Human/genetics/isolation & purification
;
Prevalence
;
Respiratory Syncytial Viruses/genetics/isolation & purification
;
Respiratory Tract Infections/epidemiology/therapy/*virology
;
Reverse Transcriptase Polymerase Chain Reaction
;
Rhinovirus/genetics/isolation & purification
;
Seasons
;
Young Adult
2.Characteristics of Hospitalized Children with 2009 Pandemic Influenza A (H1N1): A Multicenter Study in Korea.
Jeong Hee KO ; Ji Hye KIM ; Jin Han KANG ; Jong Hyun KIM ; Byung Wook EUN ; Kyung Hyo KIM ; Jung Youn HONG ; Sung Hee OH
Journal of Korean Medical Science 2012;27(4):408-415
The majority of Korean patients with pandemic influenza A (H1N1) during the 2009 epidemic were under 20 yr of age. The limited data on the clinical characteristics of these children led us to conduct a case note-based investigation of children admitted to 6 university hospitals with 2009 H1N1 influenza. A total of 804 children was enrolled. The median age was 5 yr; 63.8% were males; and 22.4% had at least one chronic underlying disease. Ninety-five of the patients (11.8%) were critically ill and they suffered more from shortness of breath, dyspnea and lymphopenia than the other patients. Among all the patients, 98.8% were treated with antivirals and 73% received treatment within 48 hr of illness onset. All the enrolled patients are alive and appear to have had good outcomes, probably due to the early intervention and antiviral treatment. This study deals with hospitalized children whose diagnoses of influenza A (H1N1) were confirmed, and therefore provides important new information about the clinical patterns of children with influenza A (H1N1) in Korea.
Adolescent
;
Antiviral Agents/therapeutic use
;
Child
;
Child, Hospitalized
;
Child, Preschool
;
Critical Illness
;
Dyspnea/etiology
;
Female
;
Humans
;
Infant
;
Infant, Newborn
;
Influenza A Virus, H1N1 Subtype/genetics/*isolation & purification
;
Influenza, Human/*diagnosis/drug therapy/epidemiology
;
Lymphopenia/etiology
;
Male
;
Oseltamivir/therapeutic use
;
Pandemics
;
Republic of Korea/epidemiology
;
Retrospective Studies